# Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication

> **NCT05585229** · PHASE2 · RECRUITING · sponsor: **University of British Columbia** · enrollment: 10 (estimated)

## Conditions studied

- Opioid Dependence
- Chronic Pain

## Interventions

- **DRUG:** Psilocybin-assisted Psychotherapy

## Key facts

- **NCT ID:** NCT05585229
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-27
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05585229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05585229, "Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05585229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*